Cite
Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis
MLA
Khay Guan Yeoh, et al. “Evaluating the Use of MicroRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.” Value in Health, vol. 23, Sept. 2020, pp. 1171–79. EBSCOhost, https://doi.org/10.1016/j.jval.2020.04.1829.
APA
Khay Guan Yeoh, Ritika Kapoor, Joanne Su-yin Yoong, Jimmy Bok Yan So, Heng-Phon Too, & Feng Zhu. (2020). Evaluating the Use of microRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis. Value in Health, 23, 1171–1179. https://doi.org/10.1016/j.jval.2020.04.1829
Chicago
Khay Guan Yeoh, Ritika Kapoor, Joanne Su-yin Yoong, Jimmy Bok Yan So, Heng-Phon Too, and Feng Zhu. 2020. “Evaluating the Use of MicroRNA Blood Tests for Gastric Cancer Screening in a Stratified Population-Level Screening Program: An Early Model-Based Cost-Effectiveness Analysis.” Value in Health 23 (September): 1171–79. doi:10.1016/j.jval.2020.04.1829.